Speaker Faculty

“An extraordinary alliance of physicians, scientists and pharma!”

Professor in Cancer Genetics, University of Birmingham

Anang Shelat

Professor & Director - Compound Management & Discovery Informatics Lead

St. Jude Children’s Research Hospital

Ani Michaud

Research Scientist


Arne Nedergaard Koshoult


The Netherlands Cancer Institute

Charles Sinclair

Head of Translational Sciences, Pioneering Medicines

Flagship Pioneering

Christopher Price

Senior Manager, Global Regulatory Oncology

Merck Healthcare KGaA

Chun-Pyn Shen

Vice President & Head of Regulatory Affairs

IMPACT Therapeutics

David Mankoff


Perelman School of Medicine at the University of Pennsylvania

Eric Brown


Aprea Therapeutics

Erik Sulman

Co-Director, Brain Tumor Center

NYU Langone

Frank Zenke

Global Head DNA Damage Response Research, Translational Innovation Platform Oncology and Immuno- Oncology

EMD Serano Inc.

Geoffrey Shapiro

Director, Early Drug Development Center

Dana-Farber Cancer Institute

Hiroki Umehara

Director, Cancer Research Unit

Sumitomo Pharma

Ioannis Gounaris

Head of Clinical Development DDR

Merck KGaA

Jann Sarkaria

Professor - Radiation Oncology

Mayo Clinic

Jennifer Castro

Principal Scientist

Accent Therapeutics

Jian Wang

Global Head of Translational Oncology Regulatory Science


Jing Li

Professor of Oncology & Director of Pharmacology & Metabolomics Core

Wayne State University School of Medicine

Jon Hollick

Managing Director & Head of Research

Breakpoint Therapeutics

Kieran Pinto

DDR Analyst

Beacon Intelligence

Kirk Tanner

Chief Scientific Officer

National Brain Tumor Society

Kirsten Timms

SVP Biomarker Discovery

Myriad Genetics

Mads Daugaard

President & Chief Scientific Officer

Rakovina Therapeutics

Mark O’Connor

Chief Scientist, Early Oncology Discovery


Michal Zimmermann

Associate Director of Cancer Biology

Repare Therapeutics

Nimrat Chatterjee

Assistant Professor

University of Vermont, Cancer Center

Norman E. Sharpless

Nominating and Governance Committee

G1 Therapeutics

Oren Gilad

Chief Executive Officer

Aprea Therapeutics

Ranjit Bindra


Modifi Bio

Ritesh Jain

Director, Global Regulatory and Scientific Policy

EMD Serono

Robert Heald

Vice President of Chemistry

Artios Pharma

Sabine Lindner

Global Regulatory Affairs Director, Oncology Regulatory Science and Strategy


Shridar Ganesan


Rutgers Cancer Institute of New Jersey

Sonia Rodrigues, MSc PhD

Executive Director Oncology Regulatory Science and Strategy, Hematology Head


Steve Warner

Senior Vice President & Head of US Research

Sumitomo Pharma Oncology

Sui Xiong Cai

Senior Vice President & Chief Technology Officer Oncology

IMPACT Therapeutics

Tarig Bashir

Chief Executive Officer

FoRx Therapeutics

Timothy Yap

Medical Director

MD Anderson Cancer Centre